serine has been researched along with simvastatin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amani, A; Deiham, B; Doosti, M; Faramarzi, MA; Imanparast, F; Kobarfard, F; Paknejad, M; Vatannejad, A | 1 |
| Bartkowiak, A; Bilewicz, R; Gajda, E; Gaweł, D; Godlewska, M; Jabłonowska, E; Nazaruk, E | 1 |
2 other study(ies) available for serine and simvastatin
| Article | Year |
|---|---|
mZD7349 peptide-conjugated PLGA nanoparticles directed against VCAM-1 for targeted delivery of simvastatin to restore dysfunctional HUVECs.
Topics: Anti-Inflammatory Agents; Cells, Cultured; Drug Carriers; Drug Compounding; Drug Liberation; Human Umbilical Vein Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Lactic Acid; Nanoparticles; Nitric Oxide Synthase Type III; Peptides, Cyclic; Phosphorylation; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Serine; Simvastatin; Solubility; Time Factors; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2017 |
Simvastatin Coadministration Modulates the Electrostatically Driven Incorporation of Doxorubicin into Model Lipid and Cell Membranes.
Topics: Antineoplastic Agents; Cell Membrane; Cholesterol; Doxorubicin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Serine; Simvastatin; Trypan Blue | 2022 |